Screener
MBX Biosciences, Inc. MBX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| General and administrative | 8,791 | 4,124 |
| Total operating expenses | 27,265 | 26,529 |
| Loss from operations | (27,265) | (26,529) |
| Interest and other income, net | 3,748 | 2,649 |
| Net loss | $(23,517) | $(23,880) |
| Unrealized loss on marketable securities | (892) | (2) |
| Total other comprehensive loss | (892) | (2) |
| Total comprehensive loss | $(24,409) | $(23,882) |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s interest income?
- MBX Biosciences, Inc. (MBX) reported interest income of $3.75M in Q1 2026.
- How has MBX Biosciences, Inc.'s interest income changed year-over-year?
- MBX Biosciences, Inc.'s interest income increased by 41.5% year-over-year, from $2.65M to $3.75M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about MBX Biosciences, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude